Medway School of Pharmacy

Medway School of Pharmacy

Medical examination in a doctor's room

General Pharmacy Practice - PCert, PDip, MSc

2019

This programme provides general-level hospital pharmacists – registered with the GPhC and working – with the core skills required to provide holistic pharmaceutical care in the practice setting.

Overview

The programme aligns with a nationally agreed pharmacy practitioner development strategy and is the result of a unique collaboration of higher education institutions across London and the south and east of England.

The programme develops your knowledge and skills in clinical pharmacy practice and medicines management. It works on a philosophy of student-centred workplace learning, supported by workbooks and contact days facilitated by experienced pharmacy practitioners. You are expected to take responsibility for managing your learning and achieving the programme objectives. The ethos and culture of the programme is to enhance and develop self-reliance and an adult approach to learning in support of continuing professional development.

About Medway School of Pharmacy

Medway School of Pharmacy is one of the few regional schools of pharmacy in the UK, a collaboration between the University of Kent and the University of Greenwich.

The impetus for the formation of the Medway School of Pharmacy came from the local community, who recognised the shortage of qualified pharmacists in all branches of the pharmacy profession in Kent.

The School is now recognised as an established school with accreditation from the General Pharmaceutical Council (GPhC) and the Health and Care Professions Council (HCPC). Graduates are employed in health disciplines in Kent and the south-east and more broadly across the UK.

Fees

For fees, please refer to the Medway School of Pharmacy website.

National ratings

In the Research Excellence Framework (REF) 2014, research by the School of Pharmacy was ranked 8th in the UK for research intensity.

An impressive 100% of our research-active staff submitted to the REF and 93% of our research was judged to be of international quality, with 81% of this judged world-leading or internationally excellent. The School’s environment was judged to be conducive to supporting the development of world-leading research.

Project Titles Supervisors
Circadian Rhythms and Aging Dr Gurprit Lall, Dr Aiste Steponenaite
Selection and evaluation of new universal influenza vaccine candidates using monoclonal antibodies and digitally designed HA and NA libraries & pseudotype virus screens Dr Nigel Temperton, Dr Simon Scott , Prof Jonathan Heeney (University of Cambridge)
Generation of human cytomegalovirus-pseudotyped particles and development of systems for the study of viral cell entry mechanisms, neutralizing antibody responses to infection and vaccination, and testing of potential novel therapeutics Dr Simon Scott , Dr Nigel Temperton, Dr Matthew Reeves (UCL)
The Creation of Anti-Viral Plastic Nanobodies for Diagnostics and Therapeutics via Molecular Imprinting of Synthetic Polymers Dr Andrew J Hall, Dr Nigel Temperton
Deciphering the landscape of nucleoporin and lamin function in nucleocytoplasmic communication, nuclear scaffolding and transcriptional control in disease prevention Dr Fani Papagiannouli, Dr Gurprit Lall
Cross-modal sensory integration for motor decision making. Dr Stella Koutsikou, Dr Tobias von der Haar
Development of lipid-polymer hybrid nanoparticles via microfluidics, for the intracellular delivery of nucleic acid therapeutics Dr Nathalie Lavignac, Dr Vladimir Gubala
Cross-talks of immune checkpoint pathways determine the abilities of human malignant tumours to suppress cytotoxic attacks and escape immune surveillance Dr Vadim V Sumbayev
Understanding the link between head injuries and Alzheimer's disease. Dr Romina Vuono